Global Allergy Diagnostics Market Size Study, by Product & Service (Instruments, Consumables, Services), by Test Type (In Vivo, In Vitro), by Allergen (Drug Allergens, Inhaled Allergens, Food Allergens, Other Allergens), by End User (Hospital-based Labora

Global Allergy Diagnostics Market Size Study, by Product & Service (Instruments, Consumables, Services), by Test Type (In Vivo, In Vitro), by Allergen (Drug Allergens, Inhaled Allergens, Food Allergens, Other Allergens), by End User (Hospital-based Laboratories, Diagnostic Laboratories, Other End Users) and Regional Forecasts 2022-2032

The Global Allergy Diagnostics Market is valued at approximately USD 5.96 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 11.4% over the forecast period 2024-2032. Allergy diagnostics is the branch of medical science dedicated to identifying and analysing allergic reactions in individuals. It encompasses a variety of tests and procedures aimed at pinpointing specific allergens that trigger allergic responses in patients. These diagnostic methods may include skin prick tests, blood tests, patch tests, and oral food challenges, among others. By accurately identifying the allergens causing adverse reactions, healthcare professionals can devise effective treatment plans and strategies for managing allergies in patients. Allergy diagnostics play a crucial role in healthcare, facilitating the diagnosis and management of allergic conditions to improve patients’ quality of life.

The allergy diagnostics market holds promising growth potential due to several factors, including the increasing prevalence of allergic diseases worldwide, technological advancements in diagnostic techniques, and growing demand for personalized medicine and targeted therapy. Additionally, rising awareness about early diagnosis and treatment of allergies and expansion of healthcare infrastructure in emerging economies are the prominent factors driving the growth of the market. However, high costs of allergy diagnostic instruments and stringent regulatory requirements for approval of diagnostic products are restraining the market growth. On the contrary, the integration of artificial intelligence in allergy diagnostics and the expansion of allergy testing services in retail pharmacies are creating opportunities for market growth.

The diagnostic laboratories segment dominated the market share and is expected to maintain its leading position throughout the forecast period owing to the availability of centralized facilities equipped with advanced equipment and trained personnel capable of conducting a wide range of allergy tests. Patients often rely on these laboratories to obtain accurate and reliable results for their allergy-related concerns. Additionally, diagnostic laboratories offer comprehensive allergy testing panels that cover a broad spectrum of allergens, allowing healthcare providers to identify specific triggers effectively. Moreover, the increasing prevalence of allergic diseases worldwide has led to a surge in demand for allergy testing services, driving patients to seek diagnosis and treatment in diagnostic laboratories. Furthermore, advancements in technology have enhanced the capabilities of diagnostic laboratories, enabling them to offer innovative allergy diagnostic tests with improved accuracy and efficiency. Overall, the diagnostic laboratories segment plays a crucial role in meeting the growing demand for allergy diagnostics by providing accessible, comprehensive, and reliable testing services to patients.

North America leads as the primary market for allergy diagnostics, holding the largest share in the industry during the forecast period due to the rising prevalence of allergic rhinitis, coupled with increased awareness of proper diagnostic procedures across the region. In 2022, the U.S. asserted its dominance within the North America market and is anticipated to sustain healthy growth with the highest CAGR throughout the analysis period. Factors contributing to this trend include a favorable return scenario, heightened funding for allergy diagnostic companies facilitating innovative product launches, and a surge in demand for rapid diagnostic test kits. Additionally, the U.S. witnesses a consistent increase in the population with food and skin-related allergies.

Major market players included in this report are:

Thermo Fisher Scientific Inc.

Danaher Corporation

Erba Group

Lincoln Diagnostics Inc.

Omega Diagnostics Group PLC

Siemens Healthcare Diagnostics, Inc.

Stallergenes SA

Astra Biotech GmbH

ACON Laboratories Inc.

Aesku.Group GmbH

The detailed segments and sub-segment of the market are explained below:

By Product & Service:
• Instruments
• Consumables
• Services

By Test Type:
• In Vivo
• In Vitro

By Allergen:
• Drug Allergens
• Inhaled Allergens
• Food Allergens
• Other Allergens

By End User:
• Hospital-based Laboratories
• Diagnostic Laboratories
• Other End Users

Common content for Report Description:

By Region:
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.